Drugs / BCG Vaccine IP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01250249 Comparator | Nov 2008 → Jun 2009 | — | Green Signal Biopharma Private Limited | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG Vaccine IP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01250249 ↗ |
| Known as | BCG Vaccine IP (SIIL) | “BCG Vaccine IP (SIIL)” NCT01250249 ↗ |
| Modality | Vaccine | “BCG Vaccine IP - Serum Institute of India” NCT01250249 ↗ |